Esomeprazole: Clinical Trials

86 trials of Esomeprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

72 completed, 8 unknown, 2 terminated, 2 withdrawn. 86 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 386Completed 72, Unknown 8, Terminated 2, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Phase 24Completed 3, Unknown 1

Follow Esomeprazole: new trials by email Literature Review of Esomeprazole trials Research Report on Esomeprazole

Trials (filtered) newest first · largest first

All 86 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week
Cyanocobalamin 1000 Mcg Oral Tablet, Cyanocobalamin 1000 Mcg Sublingual Tablet, Proton Pump Inhibitor therapy only - Hypovitaminosis b 12
Phase 3Not yet recruitingTanta University232026-12-302025-05-13
Clinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux Disease
DW4421 20mg, DW4421 40mg, Esomeprazole 40mg - Erosive Reflux Disease, GERD (Gastroesophageal Reflux Disease)
Phase 3CompletedDaewon Pharmaceutical Co., Ltd.3282025-11-172026-11-12
Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication
Vonoprazan, Esomeprazole 40mg, Amoxicillin - HELICOBACTER PYLORI INFECTIONS
Phase 3UnknownChang Gung Memorial Hospital3002025-02-012025-02-12
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
JP-1366 simulation tablets, Esomeprazole Magnesium (Nexium) simulation tablets - Reflux Esophagitis (RE)
Phase 3RecruitingLivzon Pharmaceutical Group Inc.3562024-12-052025-02-27
Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
Fexuprazan, Esomeprazole - Gastro Oesophageal Reflux Disease
Phase 3CompletedUniversitas Indonesia1452024-08-282026-08-24
Vonoprazan for Helicobacter Pylori Eradication in Adolescents
Vonoprazan, Amoxicillin, Clarithromycin - Treatment Effectiveness
Phase 3CompletedAlexandria University2422024-01-012024-08-28
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
Nexium 20mg, Nexium 10mg - Erosive Esophagitis
Phase 3CompletedAstraZeneca532022-07-012026-10-13
JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis
JP-1366 20mg, Esomeprazole 40mg - Erosive Esophagitis
Phase 3CompletedOnconic Therapeutics Inc.3002022-01-172024-08-27
Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication
Vonoprazan - Helicobacter Pylori Eradication
Phase 3CompletedAin Shams University2322022-01-012023-10-26
Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
Esomeprazole, Lansoprazole, Amoxicillin - Helicobacter Pylori Infection
Phase 2 / Phase 3CompletedFinni Kollins512021-08-012023-05-17
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
Esomeprazole 40mg, Ilaprazole Sodium, Placebo 1 - Stress Ulcer Bleeding
Phase 3CompletedLivzon Pharmaceutical Group Inc.4492021-07-162023-05-03
The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers
Esomeprazole Magnesium Enteric-coated Tablets, Lifestyle adjustment - Gastroesophageal Reflux Disease
Phase 3UnknownFifth Affiliated Hospital, Sun Yat-Sen University922021-07-012021-01-06
Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
Rifabutin, Amoxicillin, Esomeprazole - Helicobacter Infections, Resistance Bacterial
Phase 3UnknownRabin Medical Center3002021-05-012021-03-10
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
Vonoprazan, Amoxicillin, Clarithromycin - Helicobacter Pylori
Phase 3CompletedTakeda5102020-04-302023-09-07
Esomeprazole to Reduce Organ Failure in Sepsis
Esomeprazole, Placebo - Sepsis, Septic Shock
Phase 3CompletedUniversità Vita-Salute San Raffaele3002020-01-282024-01-19
Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients
YYD601 20mg, Nexium 20mg, Placebos - Non-erosive Reflux Disease
Phase 3CompletedYooyoung Pharmaceutical Co., Ltd.1702019-04-102021-05-11
Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)
YYD601 40mg, Nexium 40mg, Placebos - Erosive Esophagitis
Phase 3CompletedYooyoung Pharmaceutical Co., Ltd.1702019-01-292021-05-11
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
DWP14012 40mg, DWP14012 40mg placebo, Esomeprazole 40mg - Erosive Esophagitis
Phase 3CompletedDaewoong Pharmaceutical Co. LTD.2632018-12-132020-09-03
Esomeprazole for the Prevention of Preeclampsia
Esomeprazole, Placebo - Pre-Eclampsia
Phase 3UnknownAswan University Hospital10002018-12-012019-01-10
Efficacy and Safety of HIP1601 Capsule
HIP1601, HGP1705, HIP1601 Placebo - Erosive Gastroesophageal Reflux Disease
Phase 3CompletedHanmi Pharmaceutical Company Limited2132018-10-252020-11-30

Showing 20 of 86. Sign in to see all of them.

Conditions studied

Gastroesophageal Reflux (24)  ·  Stomach Ulcer (11)  ·  Duodenal Ulcer (5)  ·  Esophagitis, Peptic (5)  ·  Dyspepsia (4)  ·  Heartburn (4)  ·  Arthritis, Rheumatoid (3)  ·  Osteoarthritis (3)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Hemorrhage (2)  ·  Hemorrhage (2)  ·  Low Back Pain (2)  ·  Peptic Ulcer (2)  ·  Pre-Eclampsia (2)  ·  Signs and Symptoms, Digestive (2)

Sponsors

AstraZeneca (36)  ·  Chinese University of Hong Kong (4)  ·  Eisai Inc. (3)  ·  Livzon Pharmaceutical Group Inc. (3)  ·  Takeda (3)  ·  HK inno.N Corporation (2)  ·  Technische Universität Dresden (2)  ·  Yooyoung Pharmaceutical Co., Ltd. (2)  ·  Ain Shams University (1)  ·  Alexandria University (1)  ·  Assiut University (1)  ·  Aswan University Hospital (1)  ·  Baylor Breast Care Center (1)  ·  Chang Gung Memorial Hospital (1)  ·  Daewon Pharmaceutical Co., Ltd. (1)

Countries

United States (21)  ·  Germany (16)  ·  Canada (12)  ·  France (12)  ·  China (11)  ·  South Korea (10)  ·  Italy (9)  ·  Norway (9)  ·  Australia (8)  ·  Japan (8)  ·  South Africa (8)  ·  Spain (8)  ·  Sweden (7)  ·  United Kingdom (7)  ·  Belgium (6)

Top investigators

Paula Fernstrom (5)  ·  Tore Lind, MD (4)  ·  Francis K Chan, MD (2)  ·  Maotsugu Oyama, MD, PhD (2)  ·  Naotsugu Oyama (2)  ·  Yufang Lu (2)  ·  Ahmed Abbas, MD (1)  ·  Ahmed Madisch, MD (1)  ·  Allan A. Vaag, MD, DMSc (1)  ·  Amy Foxx-Orenstein, D.O. (1)  ·  Ari Fahrial Syam, MD, PhD (1)

Results publications

PMID 17391505, PMID 21114792, PMID 25141241, PMID 27331882, PMID 29788903, PMID 31297231, PMID 11197288, PMID 16441468, PMID 17499604, PMID 17697200, PMID 17697201, PMID 19221370, PMID 19357404, PMID 19577008, PMID 19661245, PMID 19922626, PMID 20151726, PMID 20223367, PMID 21181319, PMID 21319944, PMID 21415072, PMID 21586712, PMID 21848799, PMID 22111863, PMID 22241513, PMID 22591121, PMID 22885561, PMID 22998687, PMID 23006321, PMID 23011351, PMID 23026499, PMID 23147520, PMID 23188121, PMID 23530709, PMID 23800403, PMID 24299323, PMID 24326741, PMID 25350223, PMID 25858519, PMID 26121349, PMID 26226096, PMID 26422097, PMID 26581750, PMID 27080034, PMID 28070941, PMID 29540336, PMID 29638148, PMID 30233140, PMID 30992071, PMID 32365359

NIH funding

2018 (2), 2004 (1), 2023 (1), U01HL072968 (1)